The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Open accessAbstract
Ebola virus infection can cause severe hemorrhagic fever with a high mortality in humans. The outbreaks of Ebola viruses in 2014 represented the most serious Ebola epidemics in history and greatly threatened public health worldwide. The development of additional effective anti-Ebola therapeutic agents is therefore quite urgent. In this study, via high throughput screening of Food and Drug Administration-approved drugs, we identified that teicoplanin, a glycopeptide antibiotic, potently prevents the entry of Ebola envelope pseudotyped viruses into the cytoplasm. Furthermore, teicoplanin also has an inhibitory effect on transcription- and replication-competent virus-like particles, with an IC50 as low as 330 nm Comparative analysis further demonstrated that teicoplanin is able to block the entry of Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) envelope pseudotyped viruses as well. Teicoplanin derivatives such as dalbavancin, oritavancin, and telavancin can also inhibit the entry of Ebola, MERS, and SARS viruses. Mechanistic studies showed that teicoplanin blocks Ebola virus entry by specifically inhibiting the activity of cathepsin L, opening a novel avenue for the development of additional glycopeptides as potential inhibitors of cathepsin L-dependent viruses. Notably, given that teicoplanin has routinely been used in the clinic with low toxicity, our work provides a promising prospect for the prophylaxis and treatment of Ebola, MERS, and SARS virus infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., et al. (2014) · Nature · doi:10.1038/nature13777 · Cited by 987
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., et al. (2011) · Nature · doi:10.1038/nature10380 · Cited by 686
Self-citationC-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., et al. (2014) · Nature · doi:10.1038/nature13027 · Cited by 610
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Towner, J. S., Sealy, T. K., Khristova, M. L., Albariño, C. G., Conlan, S., Reeder, S. A., Quan, P.-L., Lipkin, W. I., Downing, R., Tappero, J. W., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000212 · Cited by 599
Seals, D. F., Eitzen, G., Margolis, N., Wickner, W. T., & Price, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9402 · Cited by 477
Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S., Tavakoli, I., Judge, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 463
Shirato, K., Kawase, M., & Matsuyama, S. (2013) · Journal of Virology · doi:10.1128/jvi.01890-13 · Cited by 453
Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., & Kawaoka, Y. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001121 · Cited by 437
Saeed, M. F., Kolokoltsov, A. A., Albrecht, T., & Davey, R. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001110 · Cited by 427
Preliminary report: isolation of Ebola virus from monkeys imported to USA
Jahrling, P. B., Geisbert, T. W., Johnson, E. D., Peters, C. J., Dalgard, D. W., & Hall, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90737-p · Cited by 403
Isolation and partial characterisation of a new strain of Ebola virus
Le Guenno, B., Formenty, P., Wyers, M., Gounon, P., Walker, F., & Boesch, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90925-7 · Cited by 402
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Regules, J. A., Beigel, J. H., Paolino, K. M., Voell, J., Castellano, A. R., Hu, Z., Muñoz, P., Moon, J. E., Ruck, R. C., Bennett, J. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1414216 · Cited by 387
Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., Davey, R. A., Hunt, C. L., Moller-Tank, S., Meyerholz, D. K., Rennert, P., Mullins, R. F., Brindley, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019030108 · Cited by 377
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E. B., Payne, R., Fehling, S. K., Strecker, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1411627 · Cited by 348
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.
(1978) · Europe PMC (PubMed Central) · Cited by 325
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Larsen, T., Kagan, E., & Hensley, L. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63592-4 · Cited by 318
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses
Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H., & Kawaoka, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01157-06 · Cited by 292
Cathepsin L and Cathepsin B Mediate Reovirus Disassembly in Murine Fibroblast Cells
Ebert, D. H., Deussing, J., Peters, C., & Dermody, T. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201107200 · Cited by 279
Bröcker, C., Kuhlee, A., Gatsogiannis, C., kleine Balderhaar, H. J., Hönscher, C., Engelbrecht-Vandré, S., Ungermann, C., & Raunser, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117797109 · Cited by 262
A broad-spectrum antiviral targeting entry of enveloped viruses
Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q., Aguilar, H. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909587107 · Cited by 254
Folate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses
Chan, S. Y., Empig, C. J., Welte, F. J., Speck, R. F., Schmaljohn, A. L., Kreisberg, J. F., & Goldsmith, M. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00418-4 · Cited by 208
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
Gramberg, T., Hofmann, H., Möller, P., Lalor, P. F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F., Adams, D. H., et al. (2005) · Virology · doi:10.1016/j.virol.2005.06.026 · Cited by 203
Filoviridae: a Taxonomic Home for Marburg and Ebola Viruses ?
Kiley, M. P., Bowen, E. T. W., Eddy, G. A., Isaäcson, M., Johnson, K. M., McCormick, J. B., Murphy, F. A., Pattyn, S. R., Peters, D., Prozesky, O. W., et al. (1982) · Intervirology · doi:10.1159/000149300 · Cited by 195
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Gehring, G., Rohrmann, K., Atenchong, N., Mittler, E., Becker, S., Dahlmann, F., Pöhlmann, S., Vondran, F. W. R., David, S., Manns, M. P., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku091 · Cited by 178
Watt, A., Moukambi, F., Banadyga, L., Groseth, A., Callison, J., Herwig, A., Ebihara, H., Feldmann, H., & Hoenen, T. (2014) · Journal of Virology · doi:10.1128/jvi.01272-14 · Cited by 161
Teicoplanin versus vancomycin for proven or suspected infection
Cavalcanti, A. B., Gonçalves, A., Almeida, C. S., Bugano, D. D. G., & Silva, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007022.pub2 · Cited by 127
The HOPS Proteins hVps41 and hVps39 Are Required for Homotypic and Heterotypic Late Endosome Fusion
Pols, M. S., ten Brink, C., Gosavi, P., Oorschot, V. M. J., & Klumperman, J. (2012) · Traffic · doi:10.1111/tra.12027 · Cited by 117
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
Wang, Y., Cui, R., Li, G., Gao, Q., Yuan, S., Altmeyer, R. M., & Zou, G. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.003 · Cited by 77
Antiretroviral Activity of Semisynthetic Derivatives of Glycopeptide Antibiotics
Balzarini, J. M., Pannecouque, C. C., Clercq, E. D., Pavlov, A. Y., Printsevskaya, S. S., Miroshnikova, O. V., Reznikova, M. I., & PREOBRAZHENSKAYA, M. N. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300882 · Cited by 62
Andrault, P.-M., Samsonov, S. A., Weber, G., Coquet, L., Nazmi, K., Bolscher, J. G. M., Lalmanach, A.-C., Jouenne, T., Brömme, D., Pisabarro, M. T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00231 · Cited by 59
Balzarini, J. M., Keyaerts, E., Vijgen, L., Egberink, H. F., Clercq, E. D., Ranst, M. A. V., Printsevskaya, S. S., Olsufyeva, E. N., Solovieva, S. E., & PREOBRAZHENSKAYA, M. N. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.005 · Cited by 58
Corry, J., Johnson, S. M., Cornwell, J., & Peeples, M. E. (2015) · Journal of Virology · doi:10.1128/jvi.02351-15 · Cited by 21
Cited by
Huang, Y., Yang, C., Xu, X.-F., Xu, W., & Liu, S.-W. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,224
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,265
Lai, C.-C., Liu, Y. H., Wang, C.-Y., Wang, Y.-H., Hsueh, S.-C., Yen, M.-Y., Ko, W.-C., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.02.012 · Cited by 935
The molecular virology of coronaviruses
Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J. M., & Glaunsinger, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013930 · Cited by 525
Treatment options for COVID-19: The reality and challenges
Jean, S.-S., Lee, P.-I., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.034 · Cited by 518
Metadata
- Authors
- Zhou, N., Pan, T., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., Tao, L., & Zhang, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 291
- Issue
- 17
- Pages
- 9218-9232
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2342366514
- Cited by
- 286
- References
- 38
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.